{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T13:39:48Z","timestamp":1772372388704,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.pnpbp.2017.05.004","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T21:05:38Z","timestamp":1494363938000},"page":"114-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Antidepressant drugs for beta amyloid-induced depression: A new standpoint?"],"prefix":"10.1016","volume":"78","author":[{"given":"Stefania","family":"Schiavone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Mhillaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Bove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigia","family":"Trabace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Morgese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pnpbp.2017.05.004_bb0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.ede.0000152116.32580.24","article-title":"Depression and the risk of Alzheimer disease","volume":"16","author":"Andersen","year":"2005","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.004_bb0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0006-8993(02)03153-0","article-title":"Effect of a 5-HT(2C) serotonin agonist, dexnorfenfluramine, on amyloid precursor protein metabolism in guinea pigs","volume":"951","author":"Arjona","year":"2002","journal-title":"Brain Res."},{"issue":"7354","key":"10.1016\/j.pnpbp.2017.05.004_bb0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2017.05.004_bb0020","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jns.2016.01.008","article-title":"Alzheimer's disease: An overview of amyloid beta dependent pathogenesis and its therapeutic implications along with in silico approaches emphasizing the role of natural products","volume":"361","author":"Awasthi","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.pnpbp.2017.05.004_bb0025","doi-asserted-by":"crossref","first-page":"682","DOI":"10.12998\/wjcc.v3.i8.682","article-title":"Depressive symptoms in neurodegenerative diseases","volume":"3","author":"Baquero","year":"2015","journal-title":"World J. Clin. Case."},{"issue":"4","key":"10.1016\/j.pnpbp.2017.05.004_bb0030","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/1570159X12666140828220938","article-title":"Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications","volume":"12","author":"Braun","year":"2014","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2017.05.004_bb0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fphar.2013.00161","article-title":"Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants","volume":"4","author":"Browne","year":"2013","journal-title":"Front. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2017.05.004_bb0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jad.2008.07.023","article-title":"Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy","volume":"114","author":"van Calker","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2017.05.004_bb0045","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fphar.2016.00389","article-title":"Fluoxetine prevents Abeta1-42-induced toxicity via a paracrine signaling mediated by transforming-growth-factor-beta1","volume":"7","author":"Caraci","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"Pt B","key":"10.1016\/j.pnpbp.2017.05.004_bb0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nbd.2016.07.010","article-title":"Brain-derived neurotrophic factor in mood disorders and antidepressant treatments","volume":"97","author":"Castren","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.pnpbp.2017.05.004_bb0055","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/dneu.20758","article-title":"The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity","volume":"70","author":"Castren","year":"2010","journal-title":"Dev. Neurobiol."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.004_bb0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.mp.4002101","article-title":"The amyloidogenic potential and behavioral correlates of stress","volume":"14","author":"Catania","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2017.05.004_bb0065","doi-asserted-by":"crossref","first-page":"e008853","DOI":"10.1136\/bmjopen-2015-008853","article-title":"Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis","volume":"5","author":"Cherbuin","year":"2015","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.004_bb0070","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.expneurol.2006.07.021","article-title":"Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival","volume":"203","author":"Cho","year":"2007","journal-title":"Exp. Neurol."},{"issue":"36","key":"10.1016\/j.pnpbp.2017.05.004_bb0075","doi-asserted-by":"crossref","first-page":"14968","DOI":"10.1073\/pnas.1107411108","article-title":"Serotonin signaling is associated with lower amyloid-beta levels and plaques in transgenic mice and humans","volume":"108","author":"Cirrito","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.pnpbp.2017.05.004_bb0080","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1476-5381.2010.00669.x","article-title":"Soluble beta amyloid(1-42): a critical player in producing behavioural and biochemical changes evoking depressive-related state?","volume":"159","author":"Colaianna","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.05.004_bb0085","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1471-4159.2010.06622.x","article-title":"Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity","volume":"113","author":"Counts","year":"2010","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.05.004_bb0090","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0022-3565(24)39013-5","article-title":"Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors","volume":"295","author":"Cryan","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.pnpbp.2017.05.004_bb0095","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.05.004_bb0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01628-4","article-title":"Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test","volume":"436","author":"Cryan","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.05.004_bb0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-005-0093-5","article-title":"Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment","volume":"182","author":"Cryan","year":"2005","journal-title":"Psychopharmacology"},{"issue":"4\u20135","key":"10.1016\/j.pnpbp.2017.05.004_bb0110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.05.004_bb0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cns.12484","article-title":"Role of donepezil in the management of neuropsychiatric symptoms in Alzheimer's disease and dementia with Lewy bodies","volume":"22","author":"Cummings","year":"2016","journal-title":"CNS Neurosci. Therapeut."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.004_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-1-9","article-title":"Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production","volume":"1","author":"Dello Russo","year":"2004","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.pnpbp.2017.05.004_bb0125","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2017.05.004_bb0130","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2017.05.004_bb0135","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neuroscience.2009.03.038","article-title":"Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models","volume":"161","author":"Engin","year":"2009","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.pnpbp.2017.05.004_bb0140","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1046\/j.1460-9568.2000.00126.x","article-title":"Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter","volume":"12","author":"Fabre","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.pnpbp.2017.05.004_bb0145","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1471-4159.1993.tb13425.x","article-title":"Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures","volume":"60","author":"Feinstein","year":"1993","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.004_bb0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-016-0112-5","article-title":"Redundant Gs-coupled serotonin receptors regulate amyloid-beta metabolism in vivo","volume":"11","author":"Fisher","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2017.05.004_bb0155","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1038\/sj.mp.4001015","article-title":"Delayed pharmacological effects of antidepressants","volume":"7","author":"Frazer","year":"2002","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.004_bb0160","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","article-title":"Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus","volume":"32","author":"Garcia","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2017.05.004_bb0165","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.60.5.753","article-title":"Depression as a risk factor for Alzheimer disease: the MIRAGE Study","volume":"60","author":"Green","year":"2003","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.004_bb0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003495-200161010-00005","article-title":"Cholinesterase inhibitors for Alzheimer's disease","volume":"61","author":"Grutzendler","year":"2001","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.pnpbp.2017.05.004_bb0175","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3233\/JAD-2012-111235","article-title":"5-HT(4) receptor stimulation leads to soluble AbetaPPalpha production through MMP-9 upregulation","volume":"32","author":"Hashimoto","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"13","key":"10.1016\/j.pnpbp.2017.05.004_bb0180","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1073\/pnas.0909586107","article-title":"Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine","volume":"107","author":"Heneka","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.pnpbp.2017.05.004_bb0185","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00702-010-0438-z","article-title":"Neuroinflammatory processes in Alzheimer's disease","volume":"117","author":"Heneka","year":"2010","journal-title":"J. Neural Transm."},{"issue":"2","key":"10.1016\/j.pnpbp.2017.05.004_bb0190","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(94)90362-X","article-title":"Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS","volume":"13","author":"Hewett","year":"1994","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.pnpbp.2017.05.004_bb0195","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pnpbp.2011.03.019","article-title":"Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression","volume":"35","author":"Ibrahim","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2017.05.004_bb0200","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2174\/1871527315666160321104916","article-title":"A link between nerve growth factor metabolic deregulation and amyloid-beta-driven inflammation in down syndrome","volume":"15","author":"Iulita","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.pnpbp.2017.05.004_bb0205","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-016-9952-9","article-title":"Long-term ameliorative effects of the antidepressant fluoxetine exposure on cognitive deficits in 3\u00d7TgAD Mice","author":"Jin","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.pnpbp.2017.05.004_bb0210","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1046\/j.1440-1614.2001.00967.x","article-title":"History of depression as a risk factor for dementia: an updated review","volume":"35","author":"Jorm","year":"2001","journal-title":"Australian New Zealand J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.05.004_bb0215","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neubiorev.2017.03.007","article-title":"Serotonin and neuroplasticity - links between molecular, functional and structural pathophysiology in depression","volume":"77","author":"Kraus","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5994","key":"10.1016\/j.pnpbp.2017.05.004_bb0220","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.pnpbp.2017.05.004_bb0225","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2017.05.004_bb0230","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.biopsych.2011.09.030","article-title":"Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex","volume":"71","author":"Liu","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.004_bb0235","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3233\/JAD-141062","article-title":"Norepinephrine protects against amyloid-beta toxicity via TrkB","volume":"44","author":"Liu","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"5874","key":"10.1016\/j.pnpbp.2017.05.004_bb0240","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1150516","article-title":"The antidepressant fluoxetine restores plasticity in the adult visual cortex","volume":"320","author":"Maya Vetencourt","year":"2008","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.pnpbp.2017.05.004_bb0245","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.2174\/13816128113199990500","article-title":"Modulatory activity of soluble beta amyloid on HPA axis function in rats","volume":"20","author":"Morgese","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pnpbp.2017.05.004_bb0250","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fnins.2015.00428","article-title":"Soluble beta amyloid evokes alteration in brain norepinephrine levels: role of nitric oxide and interleukin-1","volume":"9","author":"Morgese","year":"2015","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.05.004_bb0255","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s12035-016-9809-2","article-title":"Lifelong nutritional omega-3 deficiency evokes depressive-like state through soluble beta amyloid","volume":"54","author":"Morgese","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.pnpbp.2017.05.004_bb0260","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/gps.4406","article-title":"Depressive symptoms increase the risk of progression to dementia in subjects with mild cognitive impairment: systematic review and meta-analysis","volume":"31","author":"Mourao","year":"2016","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2017.05.004_bb0265","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-2010-1299","article-title":"Specific neuromodulatory actions of amyloid-beta on dopamine release in rat nucleus accumbens and caudate putamen","volume":"19","author":"Mura","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"9","key":"10.1016\/j.pnpbp.2017.05.004_bb0270","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1176\/appi.ajp.157.9.1423","article-title":"Timing of onset of antidepressant response with fluoxetine treatment","volume":"157","author":"Nierenberg","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2017.05.004_bb0275","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/JGP.0b013e3181b0fa13","article-title":"Late-life depression, mild cognitive impairment, and dementia: possible continuum?","volume":"18","author":"Panza","year":"2010","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.05.004_bb9000","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"issue":"4","key":"10.1016\/j.pnpbp.2017.05.004_bb0280","first-page":"404","article-title":"Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's type","volume":"10","author":"Pinto","year":"2011","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.05.004_bb0285","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11064-005-9029-z","article-title":"Elevation in plasma Abeta42 in geriatric depression: a pilot study","volume":"31","author":"Pomara","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pnpbp.2017.05.004_bb0290","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pnpbp.2014.10.017","article-title":"Influence of enrichment on behavioral and neurogenic effects of antidepressants in Wistar rats submitted to repeated forced swim test","volume":"58","author":"Possamai","year":"2015","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2017.05.004_bb0295","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/gps.1710","article-title":"Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly","volume":"22","author":"Qiu","year":"2007","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2017.05.004_bb0300","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","article-title":"Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders","volume":"12","author":"Ressler","year":"2000","journal-title":"Depression Anxiety"},{"issue":"7","key":"10.1016\/j.pnpbp.2017.05.004_bb0305","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.4049\/jimmunol.0803612","article-title":"Activation of microglia by amyloid beta requires P2X7 receptor expression","volume":"182","author":"Sanz","year":"2009","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.pnpbp.2017.05.004_bb0310","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1476-5381.2012.02112.x","article-title":"Nimodipine inhibits IL-1beta release stimulated by amyloid beta from microglia","volume":"167","author":"Sanz","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.pnpbp.2017.05.004_bb0315","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/gps.1417","article-title":"Behavioural and psychological signs and symptoms of dementia across cultures: current status and the future","volume":"20","author":"Shah","year":"2005","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.05.004_bb0320","doi-asserted-by":"crossref","unstructured":"Sheline YI, West T, Yarasheski K, Swarm R, Jasielec MS, Fisher JR, et al. (2014). An antidepressant decreases CSF Abeta production in healthy individuals and in transgenic AD mice. Sci. Transl. Med. 6(236): 236re234.","DOI":"10.1126\/scitranslmed.3008169"},{"issue":"6","key":"10.1016\/j.pnpbp.2017.05.004_bb0325","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nprot.2012.044","article-title":"Using the rat forced swim test to assess antidepressant-like activity in rodents","volume":"7","author":"Slattery","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.pnpbp.2017.05.004_bb0330","unstructured":"Steinberg M, Munro CA, Samus Q, P VR, Brandt J, Lyketsos CG (2004). Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS study. Int. J. Geriatr. Psychiatry 19(2): 144\u2013150."},{"issue":"12","key":"10.1016\/j.pnpbp.2017.05.004_bb0335","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/sj.npp.1300554","article-title":"Neuropathologic correlates of late-onset major depression","volume":"29","author":"Sweet","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.004_bb0340","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3565(24)39055-X","article-title":"Biochemical and neurobehavioral profile of CHF2819, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease","volume":"294","author":"Trabace","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.05.004_bb0345","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.neuroscience.2007.04.056","article-title":"Soluble amyloid beta1-42 reduces dopamine levels in rat prefrontal cortex: relationship to nitric oxide","volume":"147","author":"Trabace","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2017.05.004_bb0350","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fnbeh.2014.00332","article-title":"Memantine prevents memory consolidation failure induced by soluble beta amyloid in rats","volume":"8","author":"Tucci","year":"2014","journal-title":"Front. Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2017.05.004_bb0355","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12031-014-0277-8","article-title":"Downregulation of neuregulin 1-ErbB4 signaling in parvalbumin interneurons in the rat brain may contribute to the antidepressant properties of ketamine","volume":"54","author":"Wang","year":"2014","journal-title":"J. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2017.05.004_bb0360","first-page":"575","article-title":"Combined chronic treatment with citalopram and lithium does not modify the regional neurochemistry of nitric oxide in rat brain","volume":"55","author":"Wegener","year":"2004","journal-title":"J. Physiol. Pharmacol."},{"issue":"8","key":"10.1016\/j.pnpbp.2017.05.004_bb0365","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2165\/00002512-200421080-00004","article-title":"Time course of response to antidepressants in late-life major depression: therapeutic implications","volume":"21","author":"Whyte","year":"2004","journal-title":"Drugs Aging"},{"issue":"8","key":"10.1016\/j.pnpbp.2017.05.004_bb0370","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/gps.4409","article-title":"High amyloid-beta deposition related to depressive symptoms in older individuals with normal cognition: a pilot study","volume":"31","author":"Yasuno","year":"2016","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2017.05.004_bb0375","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.exger.2009.08.002","article-title":"Amyloid beta and APP as biomarkers for Alzheimer's disease","volume":"45","author":"Zetterberg","year":"2010","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.pnpbp.2017.05.004_bb0380","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pbb.2013.05.010","article-title":"Inhibition of the L-arginine-nitric oxide pathway mediates the antidepressant effects of ketamine in rats in the forced swimming test","volume":"110","author":"Zhang","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2017.05.004_bb0385","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neulet.2015.05.022","article-title":"Ketamine-mediated alleviation of electroconvulsive shock-induced memory impairment is associated with the regulation of neuroinflammation and soluble amyloid-beta peptide in depressive-like rats","volume":"599","author":"Zhu","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.pnpbp.2017.05.004_bb0390","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.3390\/molecules18066161","article-title":"Carvacrol: from ancient flavoring to neuromodulatory agent","volume":"18","author":"Zotti","year":"2013","journal-title":"Molecules"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584616304419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584616304419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T10:49:23Z","timestamp":1750243763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584616304419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":79,"alternative-id":["S0278584616304419"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.05.004","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant drugs for beta amyloid-induced depression: A new standpoint?","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}